Cite

HARVARD Citation

    Lin, S. et al. (2018). Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer. Endocrine-related cancer. 25 (10), pp. 853-864. [Online]. 
  
Back to record